Live Breaking News & Updates on Walters dunn

FDA Panel Rejects Pimavanserin for Alzheimer's Psychosis

An FDA advisory panel has rejected the atypical antipsychotic pimavanserin for the treatment of Alzheimer’s disease psychosis.

Johns-hopkins-university , Maryland , United-states , California , West-los-angeles , Baltimore , Madhavr-thambisetty , Howard-fillit , Los-angeles , Pierre-tariot , Walters-dunn , University-of-california

FDA Advisers Reject Nuplazid for Alzheimer's Disease Psychosis

Weak trial data not enough to persuade panel to recommend approval

New-york , United-states , Phoenix , Arizona , University-of-arizona , Texas , Madhavr-thambisetty , Paul-stander , Walters-dunn , Sonial-krishna , University-of-california-los-angeles , University-of-texas-at-austin

Prader-Willi Syndrome Drug Receives a Resounding 'No' from FDA Advisory Panel

An FDA advisory panel has voted overwhelmingly against a new drug application for intranasal carbetocin, intended to treat symptoms associated with Prader-Willi Syndrome.

California , United-states , Canada , Ottawa , Ontario , Los-angeles , Jessg-fiedorowicz , Alice-shapley , Paulb-bossie , Walters-dunn , Psychopharmacologic-drugs-advisory-committee , Drug-administration